ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Santhera Pharmaceuticals (SANN.SW)
Santhera Pharmaceuticals stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · SIX Swiss Exchange · Switzerland
CHF 15.06▲ +5.76%
Prices as of Oct 27, 2026 · CHF
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Santhera Pharmaceuticals in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Santhera Pharmaceuticals
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Santhera Pharmaceuticals a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 13.85 and CHF 16.27; in 9 out of 10, between CHF 12.01 and CHF 18.77. Estimated annual volatility is 45%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CHF 220M
- Market cap (USD)
- $266M
- 52-week high
- CHF 18.84
- 52-week low
- CHF 10.06
- Revenue (12 months)
- CHF 102M
- Gross margin
- 41.0%
- Operating margin
- -13.6%
- Net margin
- -31.5%
- Beta
- -0.39
What this means
ATLAS does not publish a fair value for SANN.SW right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks SANN.SW has traded between CHF 10.06 and CHF 18.84. Today it is 20.1% below that high and 50% above its low.
Its beta is -0.39: it tends to move less than the market.
About the company
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
Want to see everything about Santhera Pharmaceuticals?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Santhera Pharmaceuticals do?
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
What is the chance SANN.SW goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, SANN.SW ends the month between CHF 13.85 and CHF 16.27.
How big is Santhera Pharmaceuticals and what is its P/E ratio?
Santhera Pharmaceuticals's market capitalization is CHF 220M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is SANN.SW?
ATLAS estimates annual volatility at 45%. In a typical month, half of the outcomes end between CHF 13.85 and CHF 16.27.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer